{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:10:20Z","timestamp":1770455420935,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Rotterdam"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12672-019-00361-6","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T05:08:29Z","timestamp":1558156109000},"page":"107-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells"],"prefix":"10.1007","volume":"10","author":[{"given":"Aura D.","family":"Herrera-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter W.","family":"de Herder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justo P.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"G\u00e1lvez Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadime","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"van Dungen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"van Koetsveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo J.","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,18]]},"reference":[{"issue":"3","key":"361_CR1","first-page":"100","volume":"76","author":"J Hofland","year":"2018","unstructured":"Hofland J et al (2018) Recent developments in the diagnosis and therapy of well-differentiated neuroendocrine tumours. Neth J Med 76(3):100\u2013108","journal-title":"Neth J Med"},{"issue":"3","key":"361_CR2","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1530\/ERC-13-0125","volume":"21","author":"M Fraenkel","year":"2014","unstructured":"Fraenkel M et al (2014) Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer 21(3):R153\u2013R163","journal-title":"Endocr Relat Cancer"},{"key":"361_CR3","first-page":"175","volume":"02","author":"AD Herrera-Martinez","year":"2017","unstructured":"Herrera-Martinez AD, Padillo Cuenca JC, Bahamondes Opazo R, Barrera Mart\u00edn A, Rebollo Roman A, D\u00edaz Iglesia C, G\u00e1lvez Moreno MA (2017) ACTH producing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. J Pancreas 02:175\u2013180","journal-title":"J Pancreas"},{"issue":"3","key":"361_CR4","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1677\/ERC-10-0024","volume":"17","author":"G Kaltsas","year":"2010","unstructured":"Kaltsas G, Androulakis II, de Herder WW, Grossman AB (2010) Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr Relat Cancer 17(3):R173\u2013R193","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"361_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/08998280.2008.11928380","volume":"21","author":"P Fazel","year":"2008","unstructured":"Fazel P, Ganesa P, Mennel RG, Austin NA (2008) The ectopic adrenocorticotropic hormone syndrome in carcinoid tumors. Proc (Bayl Univ Med Cent) 21(2):140\u2013143","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"3","key":"361_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1530\/EJE-15-0968","volume":"174","author":"K Kamp","year":"2016","unstructured":"Kamp K, Alwani RA, Korpershoek E, Franssen GJH, de Herder WW, Feelders RA (2016) Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors. Eur J Endocrinol 174(3):271\u2013280","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"361_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1507\/endocrj.K09E-179","volume":"57","author":"T Kondo","year":"2010","unstructured":"Kondo T et al (2010) A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases. Endocr J 57(3):229\u2013236","journal-title":"Endocr J"},{"issue":"9996","key":"361_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing\u2019s syndrome. Lancet 386(9996):913\u2013927","journal-title":"Lancet"},{"issue":"6","key":"361_CR9","first-page":"752","volume":"15","author":"BL Wajchenberg","year":"1994","unstructured":"Wajchenberg BL et al (1994) Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 15(6):752\u2013787","journal-title":"Endocr Rev"},{"issue":"8","key":"361_CR10","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A (2015) Treatment of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100(8):2807\u20132831","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"361_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1210\/jc.2005-1542","volume":"91","author":"AM Isidori","year":"2006","unstructured":"Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, Jenkins PJ, Monson JP, Grossman AB, Besser GM (2006) The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91(2):371\u2013377","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"361_CR12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s00464-011-2020-7","volume":"26","author":"WJ Alberda","year":"2012","unstructured":"Alberda WJ, van Eijck CHJ, Feelders RA, Kazemier G, de Herder WW, Burger JWA (2012) Endoscopic bilateral adrenalectomy in patients with ectopic Cushing\u2019s syndrome. Surg Endosc 26(4):1140\u20131145","journal-title":"Surg Endosc"},{"issue":"2","key":"361_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1210\/jc.2012-3126","volume":"98","author":"RA Feelders","year":"2013","unstructured":"Feelders RA, Hofland LJ (2013) Medical treatment of Cushing\u2019s disease. J Clin Endocrinol Metab 98(2):425\u2013438","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"361_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2265.1981.tb00638.x","volume":"14","author":"CG Beardwell","year":"1981","unstructured":"Beardwell CG, Adamson AR, Shalet SM (1981) Prolonged remission in florid Cushing\u2019s syndrome following metyrapone treatment. Clin Endocrinol 14(5):485\u2013492","journal-title":"Clin Endocrinol"},{"issue":"4","key":"361_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1530\/eje.0.1350440","volume":"135","author":"KC Loh","year":"1996","unstructured":"Loh KC, Gupta R, Shlossberg AH (1996) Spontaneous remission of ectopic Cushing\u2019s syndrome due to pheochromocytoma: a case report. Eur J Endocrinol 135(4):440\u2013443","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"361_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1530\/EJE-11-0949","volume":"166","author":"ST Sharma","year":"2012","unstructured":"Sharma ST, Nieman LK (2012) Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing\u2019s syndrome caused by ectopic ACTH secretion. Eur J Endocrinol 166(3):531\u2013536","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"361_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1530\/acta.0.1250331","volume":"125","author":"RE Steen","year":"1991","unstructured":"Steen RE, Kapelrud H, Haug E, Frey H (1991) In vivo and in vitro inhibition by ketoconazole of ACTH secretion from a human thymic carcinoid tumour. Acta Endocrinol 125(3):331\u2013334","journal-title":"Acta Endocrinol"},{"issue":"1","key":"361_CR18","first-page":"17","volume":"78","author":"SW Lamberts","year":"1994","unstructured":"Lamberts SW et al (1994) A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing\u2019s syndrome. J Clin Endocrinol Metab 78(1):17\u201319","journal-title":"J Clin Endocrinol Metab"},{"issue":"849","key":"361_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/pgmj.72.849.403","volume":"72","author":"WW de Herder","year":"1996","unstructured":"de Herder WW, van der Lely AJ, Lamberts SW (1996) Somatostatin analogue treatment of neuroendocrine tumours. Postgrad Med J 72(849):403\u2013408","journal-title":"Postgrad Med J"},{"issue":"4","key":"361_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0002-9343(94)90059-0","volume":"96","author":"WW de Herder","year":"1994","unstructured":"de Herder WW, Krenning EP, Malchoff CD, Hofland LJ, Reubi JC, Kwekkeboom DJ, Oei HY, Pols HAP, Bruining HA, Nobels FRE, Lamberts SWJ (1994) Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing\u2019s syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med 96(4):305\u2013312","journal-title":"Am J Med"},{"issue":"8","key":"361_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/BF03347351","volume":"26","author":"GI Uwaifo","year":"2003","unstructured":"Uwaifo GI, Koch CA, Hirshberg B, Chen CC, Hartzband P, Nieman LK, Pacak K (2003) Is there a therapeutic role for octreotide in patients with ectopic Cushing\u2019s syndrome? J Endocrinol Investig 26(8):710\u2013717","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"361_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0277-5379(90)90254-Q","volume":"26","author":"LJ Hofland","year":"1990","unstructured":"Hofland LJ, van Koetsveld PM, Lamberts SW (1990) Percoll density gradient centrifugation of rat pituitary tumor cells: a study of functional heterogeneity within and between tumors with respect to growth rates, prolactin production and responsiveness to the somatostatin analog SMS 201-995. Eur J Cancer 26(1):37\u201344","journal-title":"Eur J Cancer"},{"issue":"2","key":"361_CR23","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/0003-2697(83)90212-9","volume":"131","author":"TR Downs","year":"1983","unstructured":"Downs TR, Wilfinger WW (1983) Fluorometric quantification of DNA in cells and tissue. Anal Biochem 131(2):538\u2013547","journal-title":"Anal Biochem"},{"key":"361_CR24","doi-asserted-by":"publisher","unstructured":"Borowicz S, Van Scoyk M, Avasarala S, Karuppusamy Rathinam MK, Tauler J, Bikkavilli RK, Winn RA (2014) The soft agar colony formation assay. J Vis Exp 92(E51998). \n                    https:\/\/doi.org\/10.3791\/51998","DOI":"10.3791\/51998"},{"issue":"5","key":"361_CR25","doi-asserted-by":"publisher","first-page":"E1056","DOI":"10.1152\/ajpendo.00205.2001","volume":"283","author":"D Ferone","year":"2002","unstructured":"Ferone D, Pivonello R, van Hagen PM, Dalm VASH, Lichtenauer-Kaligis EGR, Waaijers M, van Koetsveld PM, Mooy DM, Colao A, Minuto F, Lamberts SWJ, Hofland LJ (2002) Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes. Am J Physiol Endocrinol Metab 283(5):E1056\u2013E1066","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"361_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-642-59524-0_3","volume-title":"Rapid cycle real-time PCR, methods and applications","author":"R Rasmussen","year":"2001","unstructured":"Rasmussen R (2001) Quantification on the LightCycler. In: Meuer S, Wittwer C, Nakagawara K (eds) Rapid cycle real-time PCR, methods and applications. Springer Press, Heidelberg, pp 21\u201334"},{"issue":"7","key":"361_CR27","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J et al (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(7):RESEARCH0034","journal-title":"Genome Biol"},{"issue":"4","key":"361_CR28","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1210\/jc.2008-2101","volume":"94","author":"C de Bruin","year":"2009","unstructured":"de Bruin C, Pereira AM, Feelders RA, Romijn JA, Roelfsema F, Sprij-Mooij DM, van Aken MO, van der Lelij AJ, de Herder WW, Lamberts SWJ, Hofland LJ (2009) Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas. J Clin Endocrinol Metab 94(4):1118\u20131124","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"361_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101\u20131108","journal-title":"Nat Protoc"},{"issue":"9","key":"361_CR30","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 7","key":"361_CR31","doi-asserted-by":"crossref","first-page":"vii124","DOI":"10.1093\/annonc\/mds295","volume":"23","author":"K Oberg","year":"2012","unstructured":"Oberg K et al (2012) Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii124\u2013vii130","journal-title":"Ann Oncol"},{"issue":"2","key":"361_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, Krenning E, Knigge U, Salazar R, Pape UF, \u00d6berg K, all other Vienna Consensus Conference participants (2016) ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology 103(2):172\u2013185","journal-title":"Neuroendocrinology"},{"issue":"2","key":"361_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","volume":"103","author":"M Falconi","year":"2016","unstructured":"Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, Kos-Kudla B, Kwekkeboom D, Rindi G, Kl\u00f6ppel G, Reed N, Kianmanesh R, Jensen RT, all other Vienna Consensus Conference participants (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103(2):153\u2013171","journal-title":"Neuroendocrinology"},{"issue":"4","key":"361_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/00001622-200007000-00015","volume":"12","author":"RT Jensen","year":"2000","unstructured":"Jensen RT (2000) Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment. Curr Opin Oncol 12(4):368\u2013377","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"361_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1530\/eje.0.1460707","volume":"146","author":"C Bruns","year":"2002","unstructured":"Bruns C et al (2002) SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 146(5):707\u2013716","journal-title":"Eur J Endocrinol"},{"key":"361_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/j.1875-9114.1984.tb03398.x","volume":"4","author":"JH Van Tyle","year":"1984","unstructured":"Van Tyle JH (1984) Ketoconazole: mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy 4:343\u2013347","journal-title":"Pharmacotherapy"},{"issue":"2","key":"361_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1530\/acta.0.1100276","volume":"110","author":"W Heyns","year":"1985","unstructured":"Heyns W, Drochmans A, van der Schueren E, Verhoeven G (1985) Endocrine effects of high-dose ketoconazole therapy in advanced prostatic cancer. Acta Endocrinol 110(2):276\u2013283","journal-title":"Acta Endocrinol"},{"issue":"4","key":"361_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF00264198","volume":"21","author":"CF Rochlitz","year":"1988","unstructured":"Rochlitz CF et al (1988) Cytotoxicity of ketoconazole in malignant cell lines. Cancer Chemother Pharmacol 21(4):319\u2013322","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"361_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/1097-0142(19900201)65:3<446::AID-CNCR2820650312>3.0.CO;2-0","volume":"65","author":"GN Tzanakakis","year":"1990","unstructured":"Tzanakakis GN, Agarwal KC, Vezeridis MP (1990) Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma (RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole. Cancer 65(3):446\u2013451","journal-title":"Cancer"},{"issue":"2","key":"361_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0210-4806(06)73413-1","volume":"30","author":"J Huguet P\u00e9rez","year":"2006","unstructured":"Huguet P\u00e9rez J, Maroto Rey P, Palou Redorta J, Villavicencio Mavrich H (2006) C\u00e1ncer de pr\u00f3stata hormonorresistente. Cambios en las estrategias terap\u00e9uticas desde la demostraci\u00f3n de la utilidad de la quimioterapia. Actas Urol Esp 30(2):123\u2013133","journal-title":"Actas Urol Esp"},{"issue":"6","key":"361_CR41","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1097\/01.ju.0000158449.83022.40","volume":"173","author":"M Scholtz","year":"2005","unstructured":"Scholtz M, Jennrich R, Strum S, Brosman S, Johnson H, Lam R (2005) Long-term outcome with androgen independent prostate cancer treated with ketoconazole and hidrocortisone. J Urol 173(6):1947\u20131952","journal-title":"J Urol"},{"issue":"6","key":"361_CR42","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.juro.2010.02.020","volume":"183","author":"WD Figg","year":"2010","unstructured":"Figg WD, Woo S, Zhu W, Chen X, Ajiboye AS, Steinberg SM, Price DK, Wright JJ, Parnes HL, Arlen PM, Gulley JL, Dahut WL (2010) A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer. J Urol 183(6):2219\u20132226","journal-title":"J Urol"},{"issue":"6","key":"361_CR43","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s00259-015-3262-8","volume":"43","author":"A Ianniello","year":"2016","unstructured":"Ianniello A, Sansovini M, Severi S, Nicolini S, Grana CM, Massri K, Bongiovanni A, Antonuzzo L, di Iorio V, Sarnelli A, Caroli P, Monti M, Scarpi E, Paganelli G (2016) Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PET. Eur J Nucl Med Mol Imaging 43(6):1040\u20131046","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"361_CR44","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1158\/1078-0432.CCR-16-2743","volume":"23","author":"T Brabander","year":"2017","unstructured":"Brabander T, van der Zwan WA, Teunissen JJM, Kam BLR, Feelders RA, de Herder WW, van Eijck CHJ, Franssen GJH, Krenning EP, Kwekkeboom DJ (2017) Long-term efficacy, survival, and safety of [(177)Lu-DOTA(0),Tyr(3)]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors. Clin Cancer Res 23(16):4617\u20134624","journal-title":"Clin Cancer Res"},{"issue":"5","key":"361_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1634\/theoncologist.2012-0434","volume":"18","author":"JC Yao","year":"2013","unstructured":"Yao JC, Lagunes DR, Kulke MH (2013) Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learned. Oncologist 18(5):525\u2013532","journal-title":"Oncologist"},{"issue":"4","key":"361_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/CCO.0000000000000299","volume":"28","author":"M Cives","year":"2016","unstructured":"Cives M, Soares HP, Strosberg J (2016) Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials. Curr Opin Oncol 28(4):359\u2013366","journal-title":"Curr Opin Oncol"},{"issue":"12","key":"361_CR47","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","volume":"23","author":"DJ Kwekkeboom","year":"2005","unstructured":"Kwekkeboom DJ, Teunissen JJ, Bakker WH, Kooij PP, de Herder WW, Feelders RA, van Eijck CH, Esser JP, Kam BL, Krenning EP (2005) Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol 23(12):2754\u20132762","journal-title":"J Clin Oncol"},{"issue":"1","key":"361_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1677\/ERC-07-0202","volume":"15","author":"A Moreno","year":"2008","unstructured":"Moreno A, Akcakanat A, Munsell MF, Soni A, Yao JC, Meric-Bernstam F (2008) Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors. Endocr Relat Cancer 15(1):257\u2013266","journal-title":"Endocr Relat Cancer"},{"issue":"16","key":"361_CR49","first-page":"1556","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin ME, Pavel M, Ruszniewski P (2014) Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med 371(16):1556\u20131557","journal-title":"N Engl J Med"},{"issue":"28","key":"361_CR50","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"A Rinke","year":"2009","unstructured":"Rinke A, M\u00fcller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bl\u00e4ker M, Harder J, Arnold C, Gress T, Arnold R (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27(28):4656\u20134663","journal-title":"J Clin Oncol"},{"issue":"1","key":"361_CR51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1006\/taap.1998.8467","volume":"153","author":"YS Ho","year":"1998","unstructured":"Ho YS, Tsai PW, Yu CF, Liu HL, Chen RJ, Lin JK (1998) Ketoconazole-induced apoptosis through P53-dependent pathway in human colorectal and hepatocellular carcinoma cell lines. Toxicol Appl Pharmacol 153(1):39\u201347","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"361_CR52","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00204-015-1502-0","volume":"89","author":"KJ Won","year":"2015","unstructured":"Won KJ, Lee KP, Yu S, Lee D, Lee DY, Lee HM, Kim J, Jung SH, Baek S, Kim B (2015) Ketoconazole induces apoptosis in rat cardiomyocytes through reactive oxygen species-mediated Parkin overexpression. Arch Toxicol 89(10):1871\u20131880","journal-title":"Arch Toxicol"},{"issue":"7","key":"361_CR53","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.tiv.2009.07.025","volume":"23","author":"KL Lin","year":"2009","unstructured":"Lin KL, Huang CC, Cheng JS, Tsai JY, Lu YC, Chang HT, Jan CR (2009) Ketoconazole-induced JNK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicol in Vitro 23(7):1268\u20131276","journal-title":"Toxicol in Vitro"},{"issue":"2","key":"361_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jcb.10282","volume":"87","author":"YJ Wang","year":"2002","unstructured":"Wang YJ, Yu CF, Chen LC, Chen CH, Lin JK, Liang YC, Lin CH, Lin SY, Chen CF, Ho YS (2002) Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity. J Cell Biochem 87(2):147\u2013159","journal-title":"J Cell Biochem"},{"issue":"24","key":"361_CR55","first-page":"6827","volume":"52","author":"ME Forgue-Lafitte","year":"1992","unstructured":"Forgue-Lafitte ME et al (1992) Effects of ketoconazole on the proliferation and cell cycle of human cancer cell lines. Cancer Res 52(24):6827\u20136831","journal-title":"Cancer Res"},{"issue":"2","key":"361_CR56","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1006\/taap.2000.9062","volume":"169","author":"RJ Chen","year":"2000","unstructured":"Chen RJ, Lee WS, Liang YC, Lin JK, Wang YJ, Lin CH, Hsieh JY, Chaing CC, Ho YS (2000) Ketoconazole induces G0\/G1 arrest in human colorectal and hepatocellular carcinoma cell lines. Toxicol Appl Pharmacol 169(2):132\u2013141","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"361_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2265.2005.02322.x","volume":"63","author":"J van der Hoek","year":"2005","unstructured":"van der Hoek J, van der Lelij AJ, Feelders RA, de Herder WW, Uitterlinden P, Poon KW, Boerlin V, Lewis I, Krahnke T, Hofland LJ, Lamberts SW (2005) The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients. Clin Endocrinol 63(2):176\u2013184","journal-title":"Clin Endocrinol"},{"issue":"3","key":"361_CR58","first-page":"941","volume":"62","author":"B Colombo","year":"2002","unstructured":"Colombo B et al (2002) Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models. Cancer Res 62(3):941\u2013946","journal-title":"Cancer Res"},{"issue":"5","key":"361_CR59","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000125273","volume":"50","author":"R Drouhault","year":"1989","unstructured":"Drouhault R, Vacher P, David JP, Courtes AM, Vilayleck N, Dufy B (1989) Differential effects of ketoconazole on prolactin and growth hormone release by normal and tumoral rat anterior pituitary cells in vitro. Neuroendocrinology 50(5):513\u2013518","journal-title":"Neuroendocrinology"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-019-00361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-019-00361-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-019-00361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:57:51Z","timestamp":1589673471000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-019-00361-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,18]]},"references-count":59,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s12672-019-00361-6","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,18]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}